Provepharm launches UK subsidiary

2023-11-08

Opening will enable pharmaceutical company to better provide UK market with direct distribution and client-facing team. UK third direct-selling country for Provepharm, after France and the United States, expanding commercial presence in medical dye and antidote markets
 

Marseille, France, November 8, 2023 – Provepharm, a leading international pharmaceutical company specializing in medical dyes and antidotes, today announces the official launch of its dedicated United Kingdom subsidiary. This is a significant milestone in Provepharm’s strategy to establish a direct presence in key European markets, adding to its successful existing reach in France and the United States.

With the establishment of Provepharm UK, the company aims to enhance the distribution of its endoscopic and surgical dyes and antidotes offering, providing a direct route to HealthCare Professionals (HCPs) and customers. Although Provepharm’s products have been available in the UK through a distributor for several years, the launch of its UK subsidiary shows the company’s commitment to strengthening relationships with HCPs, understanding their evolving needs, and optimizing the utilization of its products to benefit patients.

“We are very proud to launch our affiliate in the UK. It will allow us to continue developing our attractiveness in the market with our holistic approach; in which we provide high-quality products and offer a solid range of educational tools to make sure our customers get the best out of our dyes,” said Michel Feraud, chairman and CEO of Provepharm. “This new initiative aims to enhance the distribution of our offering of endoscopic and surgical dyes and antidotes in the UK. Our goal is to confirm Provepharm as a trusted partner and an expert in medical dye and antidote markets.”

Provepharm’s UK affiliate offers a dedicated market-facing team, enabling the company to deliver tailored support and enhanced accessibility to its solutions. The team is fully engaged and ready to assist with existing products and future developments arising from the company’s R&D initiatives and business development opportunities.

“I am excited for the opportunities the UK affiliate will offer in terms of the development of Provepharm’s portfolio and am looking forward to building effective relationships with HCPs to ensure Provepharm UK is recognized as a valuable and trusted partner,” said Tim Whelan, UK country manager at Provepharm and head of UK operations.


Press Release

Vous allez quitter le site institutionnel de Provepharm. Si vous continuez, vous accèderez au site web de notre filiale américaine dont les informations ne s'appliquent pas nécessairement en France.